South Korea · Delayed Price · Currency is KRW Pharos iBio Statistics
Total Valuation
Pharos iBio has a market cap or net worth of KRW 65.89 billion. The enterprise value is 52.46 billion.
| Market Cap | 65.89B |
| Enterprise Value | 52.46B |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharos iBio has 12.95 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 12.95M |
| Shares Outstanding | 12.95M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 34.91% |
| Owned by Institutions (%) | 1.93% |
| Float | 8.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.78 |
| P/TBV Ratio | 7.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.33, with a Debt / Equity ratio of 0.91.
| Current Ratio | 28.33 |
| Quick Ratio | 27.40 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.27 |
| Interest Coverage | -11.39 |
Financial Efficiency
Return on equity (ROE) is -83.69% and return on invested capital (ROIC) is -41.53%.
| Return on Equity (ROE) | -83.69% |
| Return on Assets (ROA) | -33.03% |
| Return on Invested Capital (ROIC) | -41.53% |
| Return on Capital Employed (ROCE) | -41.59% |
| Weighted Average Cost of Capital (WACC) | 3.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.94% in the last 52 weeks. The beta is -0.35, so Pharos iBio's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | -8.94% |
| 50-Day Moving Average | 5,401.30 |
| 200-Day Moving Average | 7,865.43 |
| Relative Strength Index (RSI) | 48.35 |
| Average Volume (20 Days) | 64,442 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -19.62M |
| Operating Income | -10.58B |
| Pretax Income | -9.49B |
| Net Income | -9.49B |
| EBITDA | -9.72B |
| EBIT | -10.58B |
| Earnings Per Share (EPS) | -732.86 |
Balance Sheet
The company has 22.30 billion in cash and 8.87 billion in debt, with a net cash position of 13.44 billion or 1,037.96 per share.
| Cash & Cash Equivalents | 22.30B |
| Total Debt | 8.87B |
| Net Cash | 13.44B |
| Net Cash Per Share | 1,037.96 |
| Equity (Book Value) | 9.72B |
| Book Value Per Share | 749.15 |
| Working Capital | 22.33B |
Cash Flow
In the last 12 months, operating cash flow was -6.58 billion and capital expenditures -405.08 million, giving a free cash flow of -6.98 billion.
| Operating Cash Flow | -6.58B |
| Capital Expenditures | -405.08M |
| Depreciation & Amortization | 853.14M |
| Net Borrowing | 18.83B |
| Free Cash Flow | -6.98B |
| FCF Per Share | -539.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Pharos iBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | -14.40% |
| FCF Yield | -10.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |